Shelly Allen

University of Bristol, Bristol, England, United Kingdom 
Alzheimer's disease (pathophysiology, therapeutics), cholinergic systems
"Shelly Allen"
Mean distance: 106866
Cross-listing: Alzheimer's Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kailainathan S, Piers TM, Yi JH, et al. (2015) Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF). Pharmacological Research
Frias B, Santos J, Morgado M, et al. (2015) The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO). The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 2146-60
Shoemark DK, Williams C, Fahey MS, et al. (2015) Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery. Journal of Medicinal Chemistry. 58: 767-77
Shoemark DK, Allen SJ. (2015) The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 43: 725-38
Hicken EJ, Marmsater FP, Munson MC, et al. (2014) Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral Bioavailability. Acs Medicinal Chemistry Letters. 5: 78-83
Crompton LA, Byrne ML, Taylor H, et al. (2013) Stepwise, non-adherent differentiation of human pluripotent stem cells to generate basal forebrain cholinergic neurons via hedgehog signaling. Stem Cell Research. 11: 1206-21
Wang H, Sessions RB, Prime SS, et al. (2013) Identification of novel small molecule TGF-β antagonists using structure-based drug design. Journal of Computer-Aided Molecular Design. 27: 365-72
Allen SJ, Watson JJ, Shoemark DK, et al. (2013) GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacology & Therapeutics. 138: 155-75
Frias B, Allen S, Dawbarn D, et al. (2013) Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation. Neuroscience. 234: 88-102
Jackson LJ, Pheneger JA, Pheneger TJ, et al. (2012) The role of PIM kinases in human and mouse CD4+ T cell activation and inflammatory bowel disease. Cellular Immunology. 272: 200-13
See more...